glp-1 long-term side effects Your guide to GLP-1 Side Effects (2026): Common,

It is a targeted therapy called a monoclonal antibody

Introduction With high and rising rates of adiposity and related morbidity, mortality, and healthcare expenditures, recently approved glucagon-like peptide 1 receptor agonists and related combination obesity medications (collectively referred to as GLP-1s1) are shifting the treatment landscape shifting the treatment landscape (we collectively refer to these as GLP-1s given this common practical usage by clinicians, policymakers, and the public

DELIVER Trial Committees and Investigators

If you think it may be an emergency, call your local emergency number immediately

doi: 10.1111/obr.12815